Np mrd loader

Record Information
Version1.0
Created at2022-09-04 17:13:28 UTC
Updated at2022-09-04 17:13:29 UTC
NP-MRD IDNP0198731
Secondary Accession NumbersNone
Natural Product Identification
Common Name(3s,3ar,4s,9ar,9bs)-3,6,9-trimethyl-2,7-dioxo-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
Description(3S,3aR,4S,9aR,9bS)-3,6,9-trimethyl-2,7-dioxo-2H,3H,3aH,4H,5H,7H,9aH,9bH-azuleno[4,5-b]furan-4-yl acetate belongs to the class of organic compounds known as gamma butyrolactones. Gamma butyrolactones are compounds containing a gamma butyrolactone moiety, which consists of an aliphatic five-member ring with four carbon atoms, one oxygen atom, and bears a ketone group on the carbon adjacent to the oxygen atom. (3s,3ar,4s,9ar,9bs)-3,6,9-trimethyl-2,7-dioxo-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate is found in Achillea millefolium, Artemisia deserti, Artemisia tilesii and Lactuca serriola. It was first documented in 2012 (PMID: 36070501). Based on a literature review a significant number of articles have been published on (3S,3aR,4S,9aR,9bS)-3,6,9-trimethyl-2,7-dioxo-2H,3H,3aH,4H,5H,7H,9aH,9bH-azuleno[4,5-b]furan-4-yl acetate (PMID: 36070500) (PMID: 36070964) (PMID: 36070963) (PMID: 36070962) (PMID: 36070959) (PMID: 36070958).
Structure
Thumb
Synonyms
ValueSource
(3S,3AR,4S,9ar,9BS)-3,6,9-trimethyl-2,7-dioxo-2H,3H,3ah,4H,5H,7H,9ah,9BH-azuleno[4,5-b]furan-4-yl acetic acidGenerator
Chemical FormulaC17H20O5
Average Mass304.3420 Da
Monoisotopic Mass304.13107 Da
IUPAC Name(3S,3aR,4S,9aR,9bS)-3,6,9-trimethyl-2,7-dioxo-2H,3H,3aH,4H,5H,7H,9aH,9bH-azuleno[4,5-b]furan-4-yl acetate
Traditional Name(3S,3aR,4S,9aR,9bS)-3,6,9-trimethyl-2,7-dioxo-3H,3aH,4H,5H,9aH,9bH-azuleno[4,5-b]furan-4-yl acetate
CAS Registry NumberNot Available
SMILES
C[C@H]1[C@H]2[C@@H](OC1=O)[C@@H]1C(C)=CC(=O)C1=C(C)C[C@@H]2OC(C)=O
InChI Identifier
InChI=1S/C17H20O5/c1-7-5-11(19)13-8(2)6-12(21-10(4)18)15-9(3)17(20)22-16(15)14(7)13/h5,9,12,14-16H,6H2,1-4H3/t9-,12-,14+,15+,16-/m0/s1
InChI KeyQONYNSMAVSRIRD-HFDOBSEUSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Achillea millefoliumLOTUS Database
Artemisia desertiLOTUS Database
Artemisia tilesiiLOTUS Database
Lactuca serriolaLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as gamma butyrolactones. Gamma butyrolactones are compounds containing a gamma butyrolactone moiety, which consists of an aliphatic five-member ring with four carbon atoms, one oxygen atom, and bears a ketone group on the carbon adjacent to the oxygen atom.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassLactones
Sub ClassGamma butyrolactones
Direct ParentGamma butyrolactones
Alternative Parents
Substituents
  • Gamma butyrolactone
  • Dicarboxylic acid or derivatives
  • Tetrahydrofuran
  • Ketone
  • Carboxylic acid ester
  • Oxacycle
  • Carboxylic acid derivative
  • Organic oxygen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Carbonyl group
  • Aliphatic heteropolycyclic compound
Molecular FrameworkAliphatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP1.56ChemAxon
pKa (Strongest Acidic)15.02ChemAxon
pKa (Strongest Basic)-5.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area69.67 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity79.44 m³·mol⁻¹ChemAxon
Polarizability31.44 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound162944841
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Authors unspecified: Thalidomide. 2012. [PubMed:36070501 ]
  2. Authors unspecified: Lenalidomide. 2012. [PubMed:36070500 ]
  3. Uehara M, Wada-Hiraike O, Koga K, Yamamoto N, Hirano M, Harada M, Hirota Y, Osuga Y: Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study. Endocr J. 2022 Sep 7. doi: 10.1507/endocrj.EJ22-0158. [PubMed:36070964 ]
  4. Oginosawa Y: Validation of the Implantable Cardioverter-Defibrillators Indication Criteria for Nonischemic Cardiomyopathy- Why? When? How? Circ J. 2022 Sep 6. doi: 10.1253/circj.CJ-22-0478. [PubMed:36070963 ]
  5. Kodera S, Morita H, Nishi H, Takeda N, Ando J, Komuro I: Cost-Effectiveness of Dapagliflozin for Chronic Kidney Disease in Japan. Circ J. 2022 Sep 6. doi: 10.1253/circj.CJ-22-0086. [PubMed:36070962 ]
  6. Niwa R, Ichi S, Nomura R, Sato K: Hypofractionated Stereotactic Radiotherapy with CyberKnife for Large Arteriovenous Malformations and Arteriovenous Malformations Located in Eloquent Areas. Neurol Med Chir (Tokyo). 2022 Oct 15;62(10):445-450. doi: 10.2176/jns-nmc.2022-0033. Epub 2022 Sep 6. [PubMed:36070959 ]
  7. Cohen RB, Severance G, Olafson SN, Ward CL, Parsikia A, Bloom AR, Moran B, Kaplan MJ, Leung P: Laparoscopic Cholecystectomy in the Time of Coronavirus: A Level-1 Trauma Center's Experience. Am Surg. 2022 Sep 7:31348221121552. doi: 10.1177/00031348221121552. [PubMed:36070958 ]
  8. Fujino A, Tanaka Y, Abe D, Ariizumi Y, Inaji M, Maehara T: A New Technique for the Endoscopic Reconstruction of Skull Base Defects Using Multiple-balloon Catheters. Neurol Med Chir (Tokyo). 2022 Oct 15;62(10):483-487. doi: 10.2176/jns-nmc.2022-0146. Epub 2022 Sep 6. [PubMed:36070960 ]
  9. Hara R, Hasegawa E, Inoue N, Sekine A, Tanaka K, Ikuma D, Mizuno H, Oba Y, Yamanouchi M, Suwabe T, Sawa N, Kono K, Kinowaki K, Ohashi K, Ubara Y, Hoshino J: Crescentic Glomerulonephritis with Fibrinoid Vasculitis after Administration of Influenza Vaccine. Intern Med. 2023 Apr 1;62(7):1077-1080. doi: 10.2169/internalmedicine.9410-22. Epub 2022 Sep 6. [PubMed:36070955 ]
  10. Teranishi K, Mishima Y, Taniguchi T, Fujii T, Nonaka S, Kitamura T, Kondo A, Oishi H: Preliminary Experience of the Surpass Streamline Flow Diverter for Large and Giant Unruptured Internal Carotid Artery Aneurysms. Neurol Med Chir (Tokyo). 2022 Oct 15;62(10):451-457. doi: 10.2176/jns-nmc.2022-0167. Epub 2022 Sep 6. [PubMed:36070961 ]
  11. Futamura M, Ozaki Y, Makino H, Tsujimoto S, Shigesaka M, Tanaka A, Shimamoto K, Son Y, Ito T, Nomura S: Anti-MDA-5 Antibody-positive Dermatomyositis after Allogeneic Bone Marrow Transplantation for Acute Transformation of Chronic Myelogenous Leukemia. Intern Med. 2023 Apr 1;62(7):1081-1087. doi: 10.2169/internalmedicine.9529-22. Epub 2022 Sep 6. [PubMed:36070956 ]
  12. Goto R, Kawakami H, Horiuchi Y, Chikada A, Yasuda T, Suzuki T, Miyazato Y, Ishikane M, Kishino Y, Miyazaki H, Igari T, Katano H, Suzuki T, Murayama S, Arai N: An Autopsy Report of a Case with Cerebral Infarction Complicated by Coronavirus Disease 2019 Infection. Intern Med. 2022 Nov 15;61(22):3439-3444. doi: 10.2169/internalmedicine.9726-22. Epub 2022 Sep 6. [PubMed:36070957 ]
  13. Hamada O, Tsutsumi T, Imanaka Y: Efficiency of the Japanese Hospitalist System for Patients with Urinary Tract Infection: A Propensity-matched Analysis. Intern Med. 2023 Apr 15;62(8):1131-1138. doi: 10.2169/internalmedicine.8944-21. Epub 2022 Sep 6. [PubMed:36070954 ]
  14. Naito T: Will the Introduction of the Hospitalist System Save Japan? Intern Med. 2023 Apr 15;62(8):1105-1106. doi: 10.2169/internalmedicine.0693-22. Epub 2022 Sep 6. [PubMed:36070953 ]
  15. Isaac S, Pasha MA, Thinagaran JKR, Kyei-Nimako E: Letter to the editor: Delayed Metastasis of Renal Cell Carcinoma. Intern Med. 2023 May 1;62(9):1385. doi: 10.2169/internalmedicine.0674-22. Epub 2022 Sep 6. [PubMed:36070952 ]
  16. Yokoyama T, Hayashi D, Kosugi S: Nocardia Subcutaneous Abscess in a Waldenstrom Macroglobulinemia Patient. Intern Med. 2023 Apr 15;62(8):1247-1248. doi: 10.2169/internalmedicine.0496-22. Epub 2022 Sep 6. [PubMed:36070951 ]
  17. LOTUS database [Link]